Literature DB >> 26673459

Pathogenic Microorganisms and Pancreatic Cancer.

Chunsaie Wang1, Jingna Li1.   

Abstract

BACKGROUND: Pancreatic cancer is one of the most lethal cancers worldwide. No effective screening methods exist, and available treatment modalities do not effectively treat the disease. Established risk factors for pancreatic cancer, including smoking, chronic pancreatitis, obesity and type 2 diabetes mellitus, collectively account for less than half of all pancreatic cancer cases. Accumulating reports have demonstrated that there is an association between pathogenic microorganisms and pancreatic cancer.
SUMMARY: A substantial amount of preclinical and clinical evidence suggests that microbiota are likely to influence pancreatic carcinogenesis. This review summarizes the literature on studies examining infections that have been linked to pancreatic cancer. KEY MESSAGE: Helicobacter pylori infection may be a risk factor for pancreatic cancer; chronic hepatitis virus and oral microbiota may also play a role in pancreatic carcinogenesis. PRACTICAL IMPLICATIONS: Considering the worldwide burden of the disease, the association between microbiota and pancreatic cancer in this review may provide new ideas to prevent and treat pancreatic cancer more efficiently. Further studies in this direction are urgently needed.

Entities:  

Keywords:  Bacteria; Chronic hepatitis virus infection; Helicobacter pylori; Microbiome; Oral microbiota; Pancreatic cancer

Year:  2015        PMID: 26673459      PMCID: PMC4668790          DOI: 10.1159/000380896

Source DB:  PubMed          Journal:  Gastrointest Tumors        ISSN: 2296-3774


  48 in total

1.  Pancreatic cancer: Helicobacter pylori colonization, N-nitrosamine exposures, and ABO blood group.

Authors:  Harvey A Risch
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

2.  [Helicobacter pylori infection in pancreatic cancer].

Authors:  Alicja Gawin; Thomas Wex; Małgorzata Ławniczak; Peter Malfertheiner; Teresa Starzyńska
Journal:  Pol Merkur Lekarski       Date:  2012-02

Review 3.  Microbiota, oral microbiome, and pancreatic cancer.

Authors:  Dominique S Michaud; Jacques Izard
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

Review 4.  Pancreatic cancer, inflammation, and microbiome.

Authors:  Constantinos P Zambirinis; Smruti Pushalkar; Deepak Saxena; George Miller
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

Review 5.  Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective.

Authors:  Jun-Ling Han; Hui-Ling Lin
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

6.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.

Authors:  Fredrik Bäckhed; Jill K Manchester; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-08       Impact factor: 11.205

7.  A metagenome-wide association study of gut microbiota in type 2 diabetes.

Authors:  Junjie Qin; Yingrui Li; Zhiming Cai; Shenghui Li; Jianfeng Zhu; Fan Zhang; Suisha Liang; Wenwei Zhang; Yuanlin Guan; Dongqian Shen; Yangqing Peng; Dongya Zhang; Zhuye Jie; Wenxian Wu; Youwen Qin; Wenbin Xue; Junhua Li; Lingchuan Han; Donghui Lu; Peixian Wu; Yali Dai; Xiaojuan Sun; Zesong Li; Aifa Tang; Shilong Zhong; Xiaoping Li; Weineng Chen; Ran Xu; Mingbang Wang; Qiang Feng; Meihua Gong; Jing Yu; Yanyan Zhang; Ming Zhang; Torben Hansen; Gaston Sanchez; Jeroen Raes; Gwen Falony; Shujiro Okuda; Mathieu Almeida; Emmanuelle LeChatelier; Pierre Renault; Nicolas Pons; Jean-Michel Batto; Zhaoxi Zhang; Hua Chen; Ruifu Yang; Weimou Zheng; Songgang Li; Huanming Yang; Jian Wang; S Dusko Ehrlich; Rasmus Nielsen; Oluf Pedersen; Karsten Kristiansen; Jun Wang
Journal:  Nature       Date:  2012-09-26       Impact factor: 49.962

8.  Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults.

Authors:  Nadja Larsen; Finn K Vogensen; Frans W J van den Berg; Dennis Sandris Nielsen; Anne Sofie Andreasen; Bente K Pedersen; Waleed Abu Al-Soud; Søren J Sørensen; Lars H Hansen; Mogens Jakobsen
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

Review 9.  Carcinogenesis of Helicobacter pylori.

Authors:  Pelayo Correa; Jeanmarie Houghton
Journal:  Gastroenterology       Date:  2007-08       Impact factor: 22.682

10.  Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii.

Authors:  M Million; M Maraninchi; M Henry; F Armougom; H Richet; P Carrieri; R Valero; D Raccah; B Vialettes; D Raoult
Journal:  Int J Obes (Lond)       Date:  2011-08-09       Impact factor: 5.095

View more
  17 in total

1.  High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients.

Authors:  Joni Leppänen; Olli Helminen; Heikki Huhta; Joonas H Kauppila; Joel Isohookana; Kirsi-Maria Haapasaari; Petri Lehenkari; Juha Saarnio; Tuomo J Karttunen
Journal:  Virchows Arch       Date:  2017-02-12       Impact factor: 4.064

2.  Gut immunoglobulin alpha anti-glycan binding profiles as a research tool for local disease detection.

Authors:  Joseph J Otto; Crystal L Daniels; Lindsay N Schambeau; Brittany N Williams; Jana M Rocker; Lewis K Pannell
Journal:  Glycoconj J       Date:  2018-06-09       Impact factor: 2.916

Review 3.  Microbiota dysbiosis in select human cancers: Evidence of association and causality.

Authors:  Jie Chen; Jada C Domingue; Cynthia L Sears
Journal:  Semin Immunol       Date:  2017-08-16       Impact factor: 11.130

Review 4.  Strategies for Increasing Pancreatic Tumor Immunogenicity.

Authors:  Burles A Johnson; Mark Yarchoan; Valerie Lee; Daniel A Laheru; Elizabeth M Jaffee
Journal:  Clin Cancer Res       Date:  2017-04-01       Impact factor: 12.531

Review 5.  The Gut Microbiome in Pancreatic Disease.

Authors:  Venkata S Akshintala; Rupjyoti Talukdar; Vikesh K Singh; Michael Goggins
Journal:  Clin Gastroenterol Hepatol       Date:  2018-08-23       Impact factor: 11.382

Review 6.  Gut Microbiota-Immune System Crosstalk and Pancreatic Disorders.

Authors:  D Pagliari; A Saviano; E E Newton; M L Serricchio; A A Dal Lago; A Gasbarrini; R Cianci
Journal:  Mediators Inflamm       Date:  2018-02-01       Impact factor: 4.711

Review 7.  The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives.

Authors:  Lina Elsalem; Ahmad A Jum'ah; Mahmoud A Alfaqih; Osama Aloudat
Journal:  Clin Exp Gastroenterol       Date:  2020-05-06

8.  A Circulating Exosome RNA Signature Is a Potential Diagnostic Marker for Pancreatic Cancer, a Systematic Study.

Authors:  Yixing Wu; Hongmei Zeng; Qing Yu; Huatian Huang; Beatrice Fervers; Zhe-Sheng Chen; Lingeng Lu
Journal:  Cancers (Basel)       Date:  2021-05-24       Impact factor: 6.639

Review 9.  Gut microbiota in pancreatic diseases: possible new therapeutic strategies.

Authors:  Li-Long Pan; Bin-Bin Li; Xiao-Hua Pan; Jia Sun
Journal:  Acta Pharmacol Sin       Date:  2020-10-22       Impact factor: 7.169

Review 10.  Advancing Point-of-Care (PoC) Testing Using Human Saliva as Liquid Biopsy.

Authors:  Rabia Sannam Khan; Zohaib Khurshid; Faris Yahya Ibrahim Asiri
Journal:  Diagnostics (Basel)       Date:  2017-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.